Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism After Elective Total Hip Replacement Surgery
Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism After Elective Total Hip Replacement Surgery
This study is requested by PMDA to confirm the optimal dose for THR (total hip replacement).
Inclusion Criteria:
Exclusion Criteria: